Cytomedix Appoints Dr. Craig Mendelsohn to Board of Directors
13. November 2009 10:01 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Nov. 13, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Reports Third Quarter Financial Results
11. November 2009 16:20 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Nov. 11, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex: GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix to Host Third Quarter and Nine Months 2009 Financial Results Conference Call on Thursday, November 12, 2009
30. Oktober 2009 10:48 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Oct. 30, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix to Present at the 8th Annual Bio Investor Forum
27. Oktober 2009 08:00 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix to Present At Growth Stock Conference Hosted by Security Research Associates, Inc.
15. Oktober 2009 10:36 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Oct. 15, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Enters License Agreement With Millennia Holdings for Exclusive Rights to the AutoloGel System in Japan
30. September 2009 10:00 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 30, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix CEO Issues Shareholder Update
09. September 2009 08:00 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 9, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) announced today that Chief Executive Officer, Martin Rosendale, issued the following letter to shareholders providing...
Cytomedix Announces Subsequent and Final Closing of Registered Direct Offering of Common Stock and Warrants
27. August 2009 08:30 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 27, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) ("the Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Announces Registered Direct Offering of Common Stock and Warrants
12. August 2009 09:01 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 12, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) ("the Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Second Quarter Financial Results Feature Product Sales Up 72% Over First Quarter
10. August 2009 09:50 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 10, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) ("the Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...